Abstract: The invention relates to a gaseous mixture containing oxygen (O2) and a volume proportion of 20 to 70% of xenon (Xe) for use as an inhalable drug for preventing or treating hypersensitivity to pain in humans or animals, in particular hypersensitivity to pain expressed as hyperalgesia or allodynia.
Type:
Application
Filed:
July 13, 2010
Publication date:
May 24, 2012
Applicants:
Universite Bordeau Segalen, L'Air Liquide Societe Anonyme Pour L'Etude Et Exploitation Des Procedes georges Claude